References
- Mease PJ, Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann Rheum Dis (2002) 61: 298–304.
- Craven NM, Jackson CW, Kirby B et al, Cytokine gene polymorphism in psoriasis. Br J Dermatol (2001) 144: 849–53.
- Knight DM, Trinh H, Siegel S et al, Construction and initial characterisation of a mouse-human chi- meric anti-TNF antibody. Mol Immunol (1993) 30: 1443–45.
- Chaudhari U, Romano P, Mulcahy LD et al, Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet (2001) 357: 1842–47.
- Schopf RE, Aust H, Knop J, Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor a, infliximab. J Am Acad Dermatol (2002) 46: 886–91.
- Maini RN, Breedveld FC, Kalden JR et al, Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum (1998) 41: 1552–63.
- Ogilive AL, Antoni C, Dechani C et al, Treatment of psoriatic arthritis with antitumour necrosis factor-alfa antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Br J Dermatol (2001) 144: 587–89.
- Kirby B, Marsland AM, Carmichael AJ, Successful treatment of severe recalcitrant psoriasis with combina- tion infliximab and methotrexate. Clin Exp Dermatol (2001) 26: 27–29.
- Pan TD, McDonald CJ, Cytotoxic agents. In: Wolverton S E editor: Comprehensive Dermatologic Therapy, Philadelphia, 2001, W B Saunders, pp 191–193.
- Rusthoven JJ, Phillops RA, Hydroxyurea kills B cell precursors and markedly reduces functional B cell activity in mouse bone marrow. J Immunol (1980) 124 (2); 781–86.
- Streifel JA, Howell SB, Synergistic interaction between 1- beta-D-arabinofuranosylcytosine, thimidine, and hydro- xyurea against human B cells and leukemic blasts in vitro. Proc Natl Acad Sci USA (1981) 78 (8); 5132–36.
- Layton AM, Sheehan-Dare RA, Goodfield MJD et al, Hydroxyurea in the management of therapy resistant psoriasis. Br J Dermatol (1989) 121: 647–53.